Reassuring Data: Olaparib Dose Reductions Have Minimal Effect Reassuring Data: Olaparib Dose Reductions Have Minimal Effect

Dr Maurie Markman discusses a recent paper describing olaparib interruptions and dose reductions in ovarian cancer.Medscape Oncology
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news